IDOSE TR Drug Patent Profile

✉ Email this page to a colleague

When do Idose Tr patents expire, and when can generic versions of Idose Tr launch?

Idose Tr is a drug marketed by Glaukos and is included in one NDA. There are two patents protecting this drug.

This drug has fifty-two patent family members in seven countries.

The generic ingredient in IDOSE TR is travoprost. There are fifteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the travoprost profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Idose Tr

A generic version of IDOSE TR was approved as travoprost by CHARTWELL RX on March 1^st, 2013.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for IDOSE TR?
What are the global sales for IDOSE TR?
What is Average Wholesale Price for IDOSE TR?

Summary for IDOSE TR

International Patents:	52
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Patent Applications:	3,814
Drug Prices:	Drug price information for IDOSE TR
What excipients (inactive ingredients) are in IDOSE TR?	IDOSE TR excipients list
DailyMed Link:	IDOSE TR at DailyMed

Drug patent expirations by year for IDOSE TR

Pharmacology for IDOSE TR

Drug Class	Prostaglandin Analog

US Patents and Regulatory Information for IDOSE TR

IDOSE TR is protected by two US patents and one FDA Regulatory Exclusivity.

Patents protecting IDOSE TR

Implants with controlled drug delivery features and methods of using same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

FDA Regulatory Exclusivity protecting IDOSE TR

NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaukos	IDOSE TR	travoprost	IMPLANT;INTRACAMERAL	218010-001	Dec 13, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Glaukos	IDOSE TR	travoprost	IMPLANT;INTRACAMERAL	218010-001	Dec 13, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Glaukos	IDOSE TR	travoprost	IMPLANT;INTRACAMERAL	218010-001	Dec 13, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

EU/EMA Drug Approvals for IDOSE TR

Subscribe to access the full database, or Sign Up
Company	Drugname	Inn	Product Number / Indication	Status	Generic	Biosimilar	Orphan	Marketing Authorisation	Marketing Refusal
Novartis Europharm Limited	Izba	travoprost	EMEA/H/C/002738 Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 3 years to < 18 years with ocular hypertension or paediatric glaucoma.	Authorised	no	no	no	2014-02-20
Novartis Europharm Limited	Travatan	travoprost	EMEA/H/C/000390 Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1).Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1).	Authorised	no	no	no	2001-11-27
>Company	>Drugname	>Inn	>Product Number / Indication	>Status	>Generic	>Biosimilar	>Orphan	>Marketing Authorisation	>Marketing Refusal

International Patents for IDOSE TR

See the table below for patents covering IDOSE TR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2015171553	薬剤溶出眼内インプラント (DRUG ELUTING OCULAR IMPLANT)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2014150292		⤷ Sign Up
Japan	6714674		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for IDOSE TR

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1920764	PA2012017	Lithuania	⤷ Sign Up	PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
1514548	PA2014029	Lithuania	⤷ Sign Up	PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
1920764	1290027-0	Sweden	⤷ Sign Up	PRODUCT NAME: TRAVOPROST
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description